Monash IVF Looking Undervalued, Morningstar Says — Market Talk2229 GMT [Dow Jones] Monash IVF (MVF.AU) shares are looking undervalued in the wake of news it is acquiring a leading provider of ultrasounds in Sydney for A$30.1M, Morningstar argues. On the back of the deal, it raises its forecast for fiscal 2016 net profit by 17% to A$32M. As a result, its fair-value estimate rises to A$1.90/share from A$1.80. The investment-research firm says recent weakness in MVF shares suggests investors reckon recent weak IVF volume represent a longer-term trend, where it views volumes as cyclical and will bounce back. MVF last traded at A$1.52. ([email protected]; Twitter: @RobbMStewart)Copyright (c) 2015 Dow Jon
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)